Aug. 6, 2024
Researchers at UCLA Health's Jonsson Comprehensive Cancer Center have launched a pioneering clinical trial to evaluate the safety and efficacy …
Aug. 5, 2024
Lantern Pharma has announced positive preliminary results from the ongoing Phase 2 HARMONIC clinical trial, targeting never smokers with advanced …
Aug. 4, 2024
Brain-computer interface (BCI) technologies are rapidly becoming the spotlight of the neurotech industry, with Neuralink at the forefront. Recently, Neuralink …
Aug. 2, 2024
A global initiative is underway to create consensus definitions for diverse intelligent systems, including AI, LLMs, and biological intelligences. Led …
Aug. 1, 2024
Paige, an AI-powered pathology solutions provider, has announced the open-source release of its AI models, Virchow and PRISM. Available on …
Aug. 1, 2024
Healx, a clinical-stage biotechnology company specializing in rare diseases, has successfully raised $47 million in a Series C funding round. …
July 31, 2024
Montara Therapeutics, Inc. has announced the successful completion of an $8 million seed financing round, led by SV Health Investors’ …
Aug. 1, 2024
Polaroid Therapeutics (PTx), a Swiss biotech start-up, and SFM Limited (SFM), a UK-based leader in fibre development, have announced a …
July 30, 2024
A study published in Nature Microbiology details a new method for delivering therapeutic proteins to the brain using the parasite …
July 29, 2024
A clinical trial of a novel off-the-shelf stem cell therapy for knee osteoarthritis has shown significant improvements in pain relief …
July 29, 2024
BioAge Labs, Inc. has announced the dosing of the first patient in the STRIDES Phase 2 clinical trial. This study …
July 29, 2024
D-Wave Quantum Inc., the world’s first commercial supplier of quantum computers, has announced an extension of its Leap quantum cloud …
